U.S.,Oct. 2 — ClinicalTrials.gov registry received facts related to the study (NCT07202351) titled ‘Targeted Intervention on Sleep Disorders During Tobacco or Cannabis Cessation Therapy’ on Sept. 16.
Brief Summary: During a cessation therapy for tobacco or cannabis, sleep disorders are one of the main risk factors of relapse, and a symptom of substance withdrawing. In this study, we make the hypothesis that identifying and managing potential sleep disorders during cessation treatment may contribute to maintain tobacco / cannabis abstinence on the long-term.To evaluate the impact of such intervention, we will conduct a randomised pilot study among patients consulting at two addiction prevention and care centres, for smoking or cannabis cessation.